These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 19515410)

  • 21. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
    Hanley AJ; Retnakaran R; Qi Y; Gerstein HC; Perkins B; Raboud J; Harris SB; Zinman B
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3824-32. PubMed ID: 19622625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
    Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
    Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.
    Song Y; Manson JE; Tinker L; Howard BV; Kuller LH; Nathan L; Rifai N; Liu S
    Diabetes Care; 2007 Jul; 30(7):1747-52. PubMed ID: 17468352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
    Koivula RW; Forgie IM; Kurbasic A; Viñuela A; Heggie A; Giordano GN; Hansen TH; Hudson M; Koopman ADM; Rutters F; Siloaho M; Allin KH; Brage S; Brorsson CA; Dawed AY; De Masi F; Groves CJ; Kokkola T; Mahajan A; Perry MH; Rauh SP; Ridderstråle M; Teare HJA; Thomas EL; Tura A; Vestergaard H; White T; Adamski J; Bell JD; Beulens JW; Brunak S; Dermitzakis ET; Froguel P; Frost G; Gupta R; Hansen T; Hattersley A; Jablonka B; Kaye J; Laakso M; McDonald TJ; Pedersen O; Schwenk JM; Pavo I; Mari A; McCarthy MI; Ruetten H; Walker M; Pearson E; Franks PW;
    Diabetologia; 2019 Sep; 62(9):1601-1615. PubMed ID: 31203377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women with normal glucose tolerance and a history of gestational diabetes show significant impairment of β-cell function at normal insulin sensitivity.
    Molęda P; Homa K; Safranow K; Celewicz Z; Fronczyk A; Majkowska L
    Diabetes Metab; 2013 Apr; 39(2):155-62. PubMed ID: 23369626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative contributions of insulin resistance and β-cell dysfunction to the development of Type 2 diabetes in Koreans.
    Kim CH; Kim HK; Kim EH; Bae SJ; Park JY
    Diabet Med; 2013 Sep; 30(9):1075-9. PubMed ID: 23600561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.
    Joseph JJ; Echouffo Tcheugui JB; Effoe VS; Hsueh WA; Allison MA; Golden SH
    J Am Heart Assoc; 2018 Sep; 7(17):e009890. PubMed ID: 30371168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart Rate, Autonomic Function, and Future Changes in Glucose Metabolism in Individuals Without Diabetes: The Whitehall II Cohort Study.
    Hansen CS; Færch K; Jørgensen ME; Malik M; Witte DR; Brunner EJ; Tabák AG; Kivimäki M; Vistisen D
    Diabetes Care; 2019 May; 42(5):867-874. PubMed ID: 30940642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.
    Azevedo Da Silva M; Dugravot A; Balkau B; Roussel R; Fumeron F; Elbaz A; Canonico M; Singh-Manoux A; Nabi H;
    Int J Epidemiol; 2015 Dec; 44(6):1927-40. PubMed ID: 26245205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes.
    Tanabe N; Saito K; Yamada Y; Takasawa T; Seki N; Suzuki H
    Intern Med; 2009; 48(6):401-9. PubMed ID: 19293537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.
    Festa A; Haffner SM; Wagenknecht LE; Lorenzo C; Hanley AJ
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4152-9. PubMed ID: 23884776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study of exercise on improvement of β-cell function and insulin resistance in non-diabetic young offsprings of diabetic patients.
    Yu X; Chen P; Wang H; Jin H; Jia W; Wang L
    J Endocrinol Invest; 2014 Apr; 37(4):353-8. PubMed ID: 24682911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.